Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 4 boards, counting each seat separately. Longest: Oric Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
C4 Therapeutics Inc. June 18, 202599.6%
-
Oric Pharmaceuticals Inc. June 11, 202599.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | MBX Biosciences Inc. | Grant or award | +71,000 | — | — |
| May 1, 2026 | MBX Biosciences Inc. | Grant or award | +11,938 | — | — |
| Oct 17, 2025 | MBX Biosciences Inc. | Open-market purchase | +20,000 | $13.25 | $265,000 |
Questions about Steven L. Hoerter
What boards is Steven L. Hoerter on?
Steven L. Hoerter sits on the boards of C4 Therapeutics Inc., MBX Biosciences Inc., Oric Pharmaceuticals Inc. and Yarrow Bioscience Inc.
What company is Steven L. Hoerter the CEO of?
Steven L. Hoerter is President and CEO of MBX Biosciences Inc.
How long has Steven L. Hoerter served on boards?
Our records show at least 7 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.